Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
139.45
+6.64 (5.00%)
Apr 17, 2026, 2:37 PM IST
86.26% (1Y)
| Market Cap | 3.30B +76.6% |
| Revenue (ttm) | 1.47B -0.5% |
| Net Income | 96.61M +124.8% |
| EPS | 4.09 +125.1% |
| Shares Out | 23.66M |
| PE Ratio | 34.12 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,521 |
| Average Volume | 6,110 |
| Open | 138.00 |
| Previous Close | 132.81 |
| Day's Range | 126.30 - 139.45 |
| 52-Week Range | 71.57 - 202.06 |
| Beta | -0.02 |
| RSI | 65.44 |
| Earnings Date | May 26, 2026 |